UNIVERSITA' DEGLI STUDI DI MILANO - BICOCCA;CONSIGLIO NAZIONALE DELLE RICERCHE
发明人:
ALBERGHINA, Lilia,MORESCO, Rosa Maria,VALTORTA, Silvia,GAGLIO, Daniela
申请号：
IT201800009974
公开号：
IT201800009974A1
申请日:
2018.10.31
申请国别(地区):
IT
年份:
2020
代理人:
摘要：
The present invention concerns the field of cancer, and in particular to oncogene-driven metabolic alterations which can simultaneously influence multiple metabolic pathways, thus generating unique cancer phenotypes. The present invention relates to a pharmaceutical kit for the treatment of cancer, particularly to the combination of therapeutic treatment of glycolysis/PI3K and of glutamine metabolism targets, using anti-cancer therapeutic agents showing enhanced anti-cancer effects.
